Brain diseases have no cures and affect 1 in 10 people worldwide and their families. BRAINCURES aims to tackle brain diseases with precision medicine based on the code for brain function. Our landmark decoding of the molecular framework behind brain health pinpointed SMART Target-Biology linkages that now empower novel translational avenues to conquer brain diseases through SMART Patient Stratification and SMART Treatments. The application of our proprietary platform technologies will lead to personalized treatments for the 350 million people worldwide living with depression, 48 million with Alzheimer’s disease, 21 million with schizophrenia, 6 million with Parkinson’s disease, and 350 million with rare diseases.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 2 Royal College Street, London,london Nw10nh,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.braincures.com/
- Keywords
- Sungnam-si.
- HQ
- London, London
Braincures Questions
Braincures's website is http://www.braincures.com/
Braincures's LinkedIn profile is https://uk.linkedin.com/company/braincures
Braincures has
2 employees.
View email and phone details for 2
employees at Braincures.
Braincures's industry is
Pharmaceutical Manufacturing
Braincures's top competitors are
Hantai Pharma,
Network For Aging Research - University Of Waterloo,
Korecyte Bio,
Bio2business Ltd,
Adregeneer,
Laverock Therapeutics,
Sublin Therapeutics,
N2 Talent,
Zhuhai Biori Biotechnology Co., Ltd,
Grand Biopharm.
Braincures's categories are Pharmaceutical Manufacturing
Braincures's founding year is 2017
